Vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO): Study protocol for a randomised placebo controlled trial

Trials

Volumn 14, Issue 1, 2013, Pages

  Parekh, Dhruv ^a,b   Dancer, Rachel C A ^a   Lax, Sian ^a   Cooper, Mark S ^a   Martineau, Adrian R ^c   Fraser, William D ^d   Tucker, Olga ^a   Alderson, Derek ^a   Perkins, Gavin D ^b   Gao Smith, Fang ^a   Thickett, David R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Acute lung injury; Oesophagectomy; One lung ventilation; Vitamin D

Indexed keywords

COLECALCIFEROL; PLACEBO; BIOLOGICAL MARKER; VITAMIN D;

ACUTE LUNG INJURY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD OXYGEN TENSION; CLINICAL PROTOCOL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG MONITORING; DRUG SAFETY; FEMALE; FIBEROPTIC OXIMETER CATHETER; HIGH RISK PATIENT; HUMAN; INFLAMMATION; LUNG EXTRAVASCULAR FLUID; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; OXYGENATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; VITAMIN BLOOD LEVEL; ADVERSE EFFECTS; BLOOD; CLINICAL TRIAL; DRUG ADMINISTRATION; ELECTIVE SURGERY; ESOPHAGUS RESECTION; METHODOLOGY; MORTALITY; ORAL DRUG ADMINISTRATION; PULMONARY EDEMA; TIME; TREATMENT OUTCOME; UNITED KINGDOM;

ACUTE LUNG INJURY; ADMINISTRATION, ORAL; BIOLOGICAL MARKERS; CLINICAL PROTOCOLS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ELECTIVE SURGICAL PROCEDURES; ESOPHAGECTOMY; GREAT BRITAIN; HUMANS; PULMONARY EDEMA; RESEARCH DESIGN; RESPIRATION, ARTIFICIAL; TIME FACTORS; TREATMENT OUTCOME; VITAMIN D;

EID: 84882795573     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-100     Document Type: Article

References (37)

1. Lewandowski K, Lewandowski M: Epidemiology of ARDS. Minerva Anestesiol 2006, 72:473-477.
2. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD: Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353:1685-1693.
3. Tandon S, Batchelor A, Bullock R, Gascoigne A, Griffin M, Hayes N, Hing J, Shaw I, Warnell I, Baudouin S: Peri-operative risk factors for acute lung injury after elective oesophagectomy. Br J Anaesth 2001, 86:633-638.
4. Schilling M, Gassmann N, Sigurdsson G, Regli B, Stoupis C, Furrer M, Signer C, Redaelli C, Büchler M: Role of thromboxane and leukotriene B4 in patients with acute respiratory distress syndrome after oesophagectomy. Br J Anaesth 1998, 80:36-40.
5. Schilling M, Eichenberger M, Maurer C, Sigurdsson G, Büchler M: Ketoconazole and pulmonary failure after esophagectomy: a prospective clinical trial. Dis Esophagus 2001, 14:37-40.
6. Kuwano H, Sumiyoshi K, Sonoda K, Kitamura K, Tsutsui S, Toh Y, Kitamura M, Sugimachi K: Relationship between preoperative assessment of organ function and postoperative morbidity in patients with oesophageal cancer. Eur J Surg 1998, 164:581-586.
7. Ferguson M, Durkin A: Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg 2002, 123:661-669.
8. Law S, Wong K, Kwok K, Chu K, Wong J: Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 2004, 240:791-800.
9. Baudouin S: Lung injury after thoracotomy. Br J Anaesth 2003, 91:132-142.
10. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000, 342:1334-1349.
11. Perkins GD, Park D, Alderson D, Cooke MW, Gao F, Gates S, Lamb SE, Mistry D, Thickett DR: The Beta Agonist Lung Injury TrIal (BALTI) - prevention trial protocol. Trials 2011, 12:79.
12. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E: Epidemic influenza and vitamin D. Epidemiol Infect 2006, 134:1129-1140.
13. Muhe L, Lulseged S, Mason KE, Simoes EA: Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet 1997, 349:1801-1804.
14. Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, Timms PM, Venton TR, Bothamley GH, Packe GE, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Mein CA, Bhaw-Rosun L, Nuamah R, Young DB, Drobniewski FA, Griffiths CJ, Martineau AR: Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci U S A 2012, 109:15449-15454.
15. Lee P, Eisman JA, Center JR: Vitamin D deficiency in critically ill patients. N Engl J Med 2009, 360:1912-1914.
16. Braun A, Chang D, Mahadevappa K, Gibbons FK, Liu Y, Giovannucci E, Christopher KB: Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill. Crit Care Med 2011, 39:671-677.
17. Braun AB, Gibbons FK, Litonjua AA, Giovannucci E, Christopher KB: Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med 2012, 40:63-72.
18. Amrein K, Sourij H, Wagner G, Holl A, Pieber TR, Smolle KH, Stojakovic T, Schnedl C, Dobnig H: Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study. Crit Care 2011, 15:R104.
19. Hughes DA, Norton R: Vitamin D and respiratory health. Clin Exp Immunol 2009, 158:20-25.
20. Zanetti M: Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 2004, 75:39-48.
21. Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW: Vitamin D decreases respiratory syncytial virus induction of NF-kappaB -linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol 2010, 184:965-974.
22. Shaykhiev R, Beisswenger C, Kandler K, Senske J, Puchner A, Damm T, Behr J, Bals R: Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol 2005, 289:L842-L848.
23. Alalwani SM, Sierigk J, Herr C, Pinkenburg O, Gallo R, Vogelmeier C, Bals R: The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. Eur J Immunol 2010, 40:1118-1126.
24. Sun J, Kong J, Duan Y, Szeto FL, Liao A, Madara JL, Li YC: Increased NFkappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 2006, 291:E315-E322.
25. Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, Zugel U, Steinmeyer A, Pollak A, Roth E, Boltz-Nitulescu G, Spittler A: Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006, 36:361-370.
26. Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, Tangpricha V: Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009, 7:28.
27. Herr C, Branschied M, Vogelmeier C, Bals R: Influence of Vitamin D on the innate immune response in cigarette smoke exposed macrophages. Eur Respir Soc Barcelona meet 2010:A4349.
28. Zhou X, Bailey-Bucktrout S, Jeker LT, Bluestone JA: Plasticity of CD4(+) FoxP3(+) T cells. Curr Opin Immunol 2009, 21:281-285.
29. Zhou L, Chong MM, Littman DR: Plasticity of CD4+ T cell lineage differentiation. Immunity 2009, 30:646-655.
30. Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, Walker LS, Lammas DA, Raza K, Sansom DM: 1,25-Dihydroxyvitamin D(3) and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009, 183:5458-5467.
31. Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother 2010, 1:100-107.
32. Perkins GD, McAuley DF, Thickett DR, Gao F: The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006, 173:281-287.
33. Craig TR, Duffy MJ, Shyamsundar M, McDowell C, O'Kane CM, Elborn JS, McAuley DF: A randomized clinical trial of hydroxymethylglutarylcoenzyme a reductase inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med 2011, 183:620-626.
34. Licker M, Tschopp JM, Robert J, Frey JG, Diaper J, Ellenberger C: Aerosolized salbutamol accelerates the resolution of pulmonary edema after lung resection. Chest 2008, 133:845-852.
35. Artigas A, Bernard GR, Carlet J, Dreyfuss D, Gattinoni L, Hudson L, Lamy M, Marini JJ, Matthay MA, Pinsky MR, Spragg R, Suter PM: The American- European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling. Intensive Care Med 1998, 24:378-398.
36. Artigas A, Bernard GR, Carlet J, Dreyfuss D, Gattinoni L, Hudson L, Lamy M, Marini JJ, Matthay MA, Pinsky MR, Spragg R, Suter PM: The American- European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med 1998, 157:1332-1347.
37. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286:1754-1758.